Chitin and Your Gut Mycobiome: Reading the Fungal Side of Your Microbiome

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

This stool-based test looks at chitin -- the tough structural polymer that forms fungal cell walls -- as a window into the fungal side of your gut microbiome (the mycobiome). Using DNA sequencing and related lab methods, it estimates fungal load and your microbiome's capacity to break chitin down via chitinase enzymes. Your result reflects your current gut ecosystem and recent diet, and may help guide steps that support a balanced microbiome.

Read more →

Understand what your gut health results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

Reading the fungal side of your gut microbiome

A chitin test looks at chitin -- a tough, natural polymer that forms the cell walls of fungi -- as a way to gauge the fungal component of your gut microbiome, often called the mycobiome. Modern versions are stool-based and use DNA sequencing (ITS profiling or metagenomics) to estimate how much fungal material is present and which chitin-degrading enzyme genes (chitinases) your microbial community carries. Some panels also quantify chitin or chitinase activity directly. Results are typically expressed relative to a reference population and reflect your current ecosystem state rather than a fixed trait, shifting with diet, medications, illness, and time.

Why this matters: bacteria dominate the gut, but a smaller fungal community lives alongside them, and chitin is its structural signature. When the balance between bacteria and fungi stays steady, digestion and local immune tone tend to run smoothly; when fungi expand or the community loses diversity, people sometimes notice more gas, bloating, or irregularity. Measuring chitin and chitin-degrading capacity gives a practical readout of how well your microbiome keeps the fungal side in check, and how your gut handles the fungal material that arrives from food and normal microbial turnover.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

What the fungal signal adds to a gut picture

Connecting biology to daily life is the value here. A chitin readout can help clarify whether digestive symptoms line up with a shift toward higher fungal load or reduced chitin-processing capacity, especially after events that disturb the microbiome such as a course of antibiotics, a major diet change, or a stretch of high stress. It can also put recent fungal-rich exposures -- mushrooms, fermented foods, or yeast-containing products -- into context, since these contribute chitin and other fungal signals that your microbes process.

Zooming out, the bacterial and fungal sides of the gut influence each other, and both feed into barrier function, immune calibration, and metabolism. Tracking chitin and chitinase capacity over time can show whether fiber diversity, fermented foods, sleep, and stress management are nudging your microbiome toward a more balanced, resilient state. The goal isn't a single perfect number; it's pattern recognition that helps you and your clinician align next steps with your biology.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

Reading a chitin and chitinase report

Your report typically summarizes fungal load and the abundance of chitin-degrading genes compared with a reference population, sometimes alongside overall mycobiome diversity. A “balanced” profile usually shows a modest fungal presence with adequate chitin-processing capacity, anchored within a diverse bacterial community.

When the fungal side is in balance, that pattern tends to align with comfortable digestion, steadier stool patterns, and calmer local immune signaling. Optimal ranges vary by person and geography, shaped by diet, transit time, and recent exposures, so the result is best read as a snapshot within a broader ecosystem.

When results show higher fungal load, reduced chitin-degrading capacity, or low overall diversity, that pattern can accompany bloating, gas, or irregularity, and is associated with a microbiome that is more reactive under stress. These findings are not a diagnosis; they highlight a functional pattern worth exploring with your history, diet quality, and other labs.

Companion data that sharpen the picture

Chitin data are most useful alongside other gut readouts -- overall microbial diversity, short-chain fatty acid production potential, organism-level results for yeasts such as Candida, and stool inflammation markers like calprotectin. Interpreted over time and paired with your symptom timeline, a chitin readout helps translate the fungal side of your microbiome into clear, evidence-guided steps for digestive comfort and long-term gut health.

Frequently Asked Questions

References

  1. Jovel J, Patterson J, Wang W, Hotte N, O'Keefe S, Mitchel T, Perry T, Kao D, Mason AL, Madsen KL, Wong, G. K.-S. (2016). Characterization of the gut microbiome using 16S or shotgun metagenomics. *Frontiers in Microbiology*, *7*, 459. https://doi.org/10.3389/fmicb.2016.00459
  2. Hill JH, Round JL (2024). Intestinal fungal-host interactions in promoting and maintaining health. *Cell Host & Microbe*, *32*(10), 1668–1680. https://doi.org/10.1016/j.chom.2024.09.010
  3. Kapitan M, Niemiec MJ, Steimle A, Frick JS, Jacobsen ID (2019). Fungi as part of the microbiota and interactions with intestinal bacteria. *Current Topics in Microbiology and Immunology*, *422*, 265–301. https://doi.org/10.1007/82_2018_117
  4. Zhou X, Zhang X, Yu J (2024). Gut mycobiome in metabolic diseases: Mechanisms and clinical implication. *Biomedical Journal*, *47*(3), 100625. https://doi.org/10.1016/j.bj.2023.100625
  5. Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F (2016). From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites. *Cell*, *165*(6), 1332–1345. https://doi.org/10.1016/j.cell.2016.05.041

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey